Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTRF7Q8)

DTT Name	Natural killer cell receptor (NKCR)
Gene Name	NKCR
DTT Type	Clinical trial target	[1]
UniProt ID	NOUNIPROTAC
TTD ID	T47891

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This DTT

1 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
NASVAC	DMIC56X	Hepatitis B virus infection	1E51.0	Phase 3	[1]
------------------------------------------------------------------------------------

References

1	In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors. Mol Immunol. 2015 Feb;63(2):320-7.